Biogenix Inc. Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 29-11-2024
- Paid Up Capital ₹ 6.92 M
as on 29-11-2024
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 12.56 Cr
as on 29-11-2024
- Satisfied Charges ₹ 1.00 Cr
as on 29-11-2024
- Revenue 21.82%
(FY 2024)
- Profit 74.22%
(FY 2024)
- Ebitda 53.55%
(FY 2024)
- Net Worth 58.08%
(FY 2024)
- Total Assets 52.96%
(FY 2024)
About Biogenix Inc.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 6.92 M.
The company currently has active open charges totaling ₹12.56 Cr. The company has closed loans amounting to ₹1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Santosh Srivastava and Dimple Srivastava serve as directors at the Company.
- CIN/LLPIN
U24304UP2016PTC082775
- Company No.
082775
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Apr 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Biogenix Inc. Private Limited offer?
Biogenix Inc. Private Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Inorganic Salts, Medical Laboratory Instruments, Rapid Test Kit, HCV Test Kit, Diagnostic Test Kit, Female Hygiene Products & Test Kits, Pregnancy Test Kits, Creatinine Test Kit, Elisa Kits.
Who are the key members and board of directors at Biogenix Inc.?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dimple Srivastava  | Director | 29-Apr-2016 | Current |
| Santosh Srivastava | Director | 29-Apr-2016 | Current |
Financial Performance of Biogenix Inc..
Biogenix Inc. Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 21.82% increase. The company also saw a substantial improvement in profitability, with a 74.22% increase in profit. The company's net worth Soared by an impressive increase of 58.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biogenix Inc.?
Unlock access to Biogenix Inc.'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Sarvarth Charitable FoundationActive 1 year 1 month
Santosh Srivastava and Dimple Srivastava are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 14 Mar 2024 | ₹2.30 Cr | Open |
Sidbi Creation Date: 27 Dec 2023 | ₹2.26 Cr | Open |
Sidbi Creation Date: 14 Oct 2022 | ₹9.65 M | Open |
How Many Employees Work at Biogenix Inc.?
Biogenix Inc. has a workforce of 66 employees as of Nov 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biogenix Inc., offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biogenix Inc.'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
